According to Zhitong Finance App News, Weilan Biotech (603739.SH) disclosed the 2026 semi-annual report. During the reporting period, the company achieved operating income of 710 million yuan, an increase of 8.80%; net profit attributable to shareholders of listed companies was 38.56 million yuan, an increase of 44.33% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 22.16 million yuan, an increase of 38.51% year on year; basic earnings per share were 0.15 yuan.

The increase in net profit attributable to shareholders of listed companies in the current period was mainly due to an increase in gross profit driven by the increase in operating income.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.